실시간 바이오 인텔리전스 · ADC · CGT

함께 비교하는 진짜 ADC · Antibody · CGT 데이터

9,268+프로그램
35+FDA 승인
4,079+모집 중
ADC 1068·Antibody 5456·CGT 2744차세대 추천 →·Data Tier →
9268프로그램35FDA 승인
0오늘 방문
568누적 방문
8122갱신 대기S–CData TierS/A/B차세대1068HER2 breast5456Antibody2744CGT→Psoriasis→NSCLC35FDA 승인
피드Data Tier차세대

추천 비교

비교 도구 →
HER2 ADCEnhertu · Kadcyla · RC48CD19 CAR-TYescarta · KymriahPD-1Keytruda · Opdivo다발골수종Darzalex · BlenrepTROP2 ADCTrodelvy · Dato-DXd · SGNectin-4 · TROP2Padcev · Trodelvy건선 IL pathwayStelara · Cosentyx · SkyriziAnti-VEGF (안과)Eylea · LucentisAnti-TNFHumira · EnbrelIL-12/23Stelara · Skyrizi아토피·IL-13Dupixent · Ebglyss혈우병 유전자치료Hemgenix · Roctavian겸상적혈구 CGTCasgevy · Lyfgenia망막·DMD 유전자치료Luxturna · Elevidys

최근 활동

RSS →

빠른 검색 · 이슈 태그

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 4,162개
다음 갱신 D-13 · 마지막 7월 13일
CGTBiologicPaolo Caimi, MDPhase 1

Allogeneic NK cells (Allogeneic NK cells)

Non Hodgkin Lymphoma; B-cell Non Hodgkin Lymphoma · Non Hodgkin Lymphoma

#NonHodgkinLymphoma#CGT#Phase1#인기#세포유전치료+4
효능 ORR 5%임상시험 58상태 RECRUITING
ADCBiologicAlliance for Clinical Trials in…Phase 3

Thioguanine (Thioguanine)

B Acute Lymphoblastic Leukemia · Leukemia

#Leukemia#ADC#Phase3#인기#항체약물접합체+4
임상시험 58상태 RECRUITING
CGTBiologicSMT bio Co., Ltd.Phase 2

allogeneic Natural Killer cell ('SMT-NK' Inj, 'SMT-NK' Inj (allogeneic Natural Killer cell))

Biliary Tract Cancer · Biliary Tract Cancer

#BiliaryTractCancer#CGT#Phase2#인기#세포유전치료+4
효능 ORR 42%임상시험 58상태 ACTIVE
CGTBiologicGeneplus-Beijing Co. Ltd.Phase 2

natural killer cell infusion (natural killer cell infusion)

Neuroblastoma · Recurrent B-Cell Childhood Acute Lymphob

#RecurrentB-CellChildhoodAcuteLym#CGT#Phase2#인기#세포유전치료+5
효능 ORR 42%임상시험 58상태 ACTIVE
ADCBiologicJanssen Research & Development,…Phase 2

PEG asparaginase (PEG asparaginase)

Precursor Cell Lymphoblastic Leukemia-Lymphoma · Leukemia

#Leukemia#ADC#Phase2#인기#항체약물접합체+4
효능 ORR 14.3%임상시험 58상태 ACTIVE
CGTBiologicCalimmune, Inc.Phase 1

Gene Modified T Cells (Gene Modified T Cells)

Prostate Cancer · Prostate Cancer

#ProstateCancer#CGT#Phase1#인기#세포유전치료+4
효능 ORR 92.9%임상시험 58상태 DISCONTINUED
ADCBiologicFondazione per la Medicina Pers…Govitecan Enables a Sequent…Phase 2

talazoparib (talazoparib)

Breast Cancer; Gastrointestinal Cancer · Cancer

#Cancer#ADC#Phase2#인기#항체약물접합체+5
효능 ORR 27.7%임상시험 58상태 RECRUITING
ADCBiologicFavrillederuxtecan for metastatic b…Phase 2

Antibody-Drug Conjugate Therapy (Antibody-Drug Conjugate Therapy)

Metastatic Bladder Urothelial Carcinoma; Metastatic Renal Pelvis and Ureter Urothelial Carcinoma · FRα

#FR#ADC#Phase2#인기#항체약물접합체+5
효능 ORR 86%임상시험 58상태 RECRUITING
ADCBiologicGlaxoSmithKlinePreclinical

Diphtheria & Tetanus Toxoids & Acellular Pertussis Vaccine Adsorbed (Diphtheria & Tetanus Toxoids & Acellular Pertussis Vaccine Adsorbed)

HIV Infections; Hepatitis B · HIV Infections

#HIVInfections#ADC#Preclinical#인기#항체약물접합체+3
효능 ORR 98.1%임상시험 58상태 ACTIVE
AntibodyRochePhase 2

atezolizumab (Tecentriq, Atezolizumab and Bevacizumab)

Hepatocellular Carcinoma · Resectable Hepatocellular Carcinoma

#ResectableHepatocellularCarcinom#Antibody#Phase2#인기#항체+5
효능 ORR 50%임상시험 58상태 DISCONTINUED
AntibodyGenentech, Inc.Phase 2

Ocrelizumab (Ocrelizumab)

Rheumatoid Arthritis · Multiple Sclerosis

#MultipleSclerosis#Antibody#Phase2#인기#항체+5
임상시험 58상태 DISCONTINUED
ADCBiologicAstraZenecaPhase 3

CDK4/6 inhibitor (CDK4/6 inhibitor)

Breast Cancer · Breast Cancer

#BreastCancer#ADC#Phase3#인기#항체약물접합체+3
효능 ORR 7.8%임상시험 58상태 RECRUITING
ADCBiologicJanssen Research & Development,…Phase 1

Apalutamide (Apalutamide)

Prostatic Neoplasms · Metastatic Prostate Cancer

#MetastaticProstateCancer#ADC#Phase1#인기#항체약물접합체+3
효능 ORR 2.6%임상시험 58상태 RECRUITING
ADCBiologicJules Bordet InstituteReleasePhase 2

Neratinib (Neratinib)

Breast Cancer; Brain Metastases · HER2

#HER2#ADC#Phase2#인기#항체약물접합체+5
효능 ORR 57.1%임상시험 58상태 RECRUITING
CGTBiologicNovartis PharmaceuticalsPhase 2

Bridging Therapy (Bridging Therapy)

Non-Hodgkin Lymphoma · Non-Hodgkin Lymphoma

#Non-HodgkinLymphoma#CGT#Phase2#인기#세포유전치료+4
효능 ORR 32.1%임상시험 58상태 DISCONTINUED
CGTBiologicGenentech, Inc.Phase 2

L-Asparaginase (L-Asparaginase)

B Lymphoblastic Leukemia · B Lymphoblastic Leukemia

#BLymphoblasticLeukemia#CGT#Phase2#인기#세포유전치료+4
효능 ORR 33%임상시험 58상태 RECRUITING
CGTBiologicRoyan InstitutePhase 1

NK cell therapy (NK cell therapy)

Glioblastoma Multiform; Recurrent Glioblastoma · Glioma Glioblastoma Multiforme

#GliomaGlioblastomaMultiforme#CGT#Phase1#인기#세포유전치료+5
효능 ORR 56.3%임상시험 58상태 ACTIVE
CGTBiologicLion TCR Pte. Ltd.Phase 1

Biological: TCR-T (Biological: TCR-T)

Recurrent Hepatocellular Carcinoma · Recurrent Hepatocellular Carcinoma

#RecurrentHepatocellularCarcinoma#CGT#Phase1#인기#세포유전치료+4
효능 ORR 11.8%임상시험 58상태 ACTIVE
CGTAAVBiologicBayerPhase 1

AAVrh.10hFXN, serotype rh.10 adeno-associated virus (AAV, AAVrh.10hFXN, serotype rh.10 adeno-associated virus, AAVrh.10hFXN, serotype rh.10 adeno-associated virus (AAV) gene transfer vector expressing the cDNA coding for human FXN)

Friedreich Ataxia; Cardiomyopathies · Friedreich Ataxia

#FriedreichAtaxia#CGT#Phase1#인기#세포유전치료+5
효능 ORR 11.9%임상시험 58상태 RECRUITING
ADCBiologicPfizerderuxtecan and tucatinibPhase 3

Tucatinib (Tucatinib)

Dynamic Tumor Resistance; Metastatic Colorectal Cancer · Metastatic Breast Cancer

#MetastaticBreastCancer#ADC#Phase3#인기#항체약물접합체+5
효능 ORR 100%임상시험 57상태 RECRUITING
CGTBiologicMultan Medical And Dental Colle…Phase 2

Isotretinoin (Isotretinoin)

Neuroblastoma · Neuroblastoma

#Neuroblastoma#CGT#Phase2#인기#세포유전치료+4
효능 ORR 95.4%임상시험 57상태 DISCONTINUED
CGTBiologicGilead SciencesPreclinical

Ledipasvir-Sofosbuvir (Ledipasvir-Sofosbuvir)

Chronic Hepatitis C (Disorder) · Chronic Hepatitis C

#ChronicHepatitisC#CGT#Preclinical#인기#세포유전치료+5
효능 ORR 1.5%임상시험 57상태 ACTIVE
ADCBiologicAstraZenecaDM1 in Oatp1a/b -/- was 1Phase 2

Cabazitaxel (Cabazitaxel)

Progressive Metastatic Castrate-Resistant Prostate Cancer · FRα

#FR#ADC#Phase2#인기#항체약물접합체+5
효능 ORR 57.7%임상시험 57상태 DISCONTINUED
AntibodyPfizerPhase 3

Elotuzumab (Elotuzumab)

Multiple Myeloma · Multiple Myeloma

#MultipleMyeloma#Antibody#Phase3#인기#항체+4
효능 ORR 100%임상시험 57상태 RECRUITING
AntibodyWei-Che KoPhase 3

Canakinumab (Canakinumab)

Skin Inflammation; Allergic Contact Dermatitis · Skin Inflammation

#SkinInflammation#Antibody#Phase3#인기#항체+5
효능 ORR 4.9%임상시험 57상태 RECRUITING

14 / 167 페이지

← 이전다음 →
전체 9,268개 프로그램 보기